Tuesday, October 20, 2020

Zydus Cadila gets USFDA nod for overactive bladder treatment drug

Zydus Cadila gets USFDA nod for overactive bladder treatment drug The company has received final approval from the United States Food and Drug Administration (USFDA) to market Solifenacin Succinate tablets, in the strengths of 5 mg and 10 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3m6oVjI
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...